"What can be more palpably absurd than the prospect held out of locomotives traveling twice as fast as stagecoaches?"
The Quarterly Review ; March edition, 1825
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6602504 | Canine coronavirus S gene and uses therefor The present invention provides the amino acid and nucleotide sequences of a CCV spike gene, and compositions containing one or more fragments of the spike gene and encoded polypeptide for prophylaxis, diagnostic purposes and treatment of CCV infections.... | 08/05/2003 |
| 6586431 | 3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives The present invention relates to compounds of the formula I, ##STR1## wherein Z1, Z2, X, Q, R1, R2 and R3 are defined as in the specification, pharmaceutical compositions containing such compounds the... | 07/01/2003 |
| 6570018 | Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol and intermediates useful therefor The present invention is directed to a novel process for the preparation of the mesylate trihydrate of the compound of formula (I), (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propano l: ##STR1## The present invention is further... | 05/27/2003 |
| 6562964 | Heterocyclic compounds as inhibitors of rotamase enzymes Compounds of the formula (I): ##STR1## wherein A, Y, R, X, R1, R2, R3 and R4 are as defined above are inhibitors of rotamase enzymes in particular FKBP-12 and FKBP-52. The compounds therefore moderate neuronal r... | 05/13/2003 |
| 6503905 | 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives The present invention relates to compounds of the formula I, ##STR1## wherein Z1, Z2, X, Q, R1, R2 and R3 are defined as in the specification, pharmaceutical compositions containing such compounds the... | 01/07/2003 |
| 6495589 | Somatostatin antagonists and agonists that act at the SST subtype 2 receptor Compounds according formula (I) A--G--Z--W and pharmaceutically acceptable salts, solvates or hydrates thereof; wherein, A is (C6 -C10)aryl, (C6 -C10)aryl-SO2, (C6 -C10)aryl-CH2 | 12/17/2002 |
| 6482801 | 9a, 11b-dehydro derivatives of 9-oxime-3-keto-6-O- methylerythromycin The invention relates to compounds of the formula ##STR1## and to pharmaceutically acceptable salts thereof, wherein R1 and R2 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds ... | 11/19/2002 |
| 6458822 | 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases The present invention relates to a compound of the formula ##STR1## wherein R1, R2, R3 and R4 are as defined above, and pharmaceutically acceptable salts and solvates thereof, that are useful, for example, as ma... | 10/01/2002 |
| 6372762 | Substituted bicyclic derivatives for treating central nervous system disorders The present invention relates to compounds of the formula ##STR1## and the pharmaceutically acceptable salts and solvates thereof wherein X1, X2, X3, R1, R2, R3 and R4 are as def... | 04/16/2002 |
| 6362195 | Branched alkoxy-substituted 2-aminopyridines as NOS inhibitors The present invention relates to 6-phenyl-pyridin-2-ylamine derivatives of the formula ##STR1## wherein R1, R2, R3 and R4 are defined as in the specification, that exhibit activity as nitric oxide synthase (NOS)... | 03/26/2002 |
| 6274618 | Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions The present invention provides novel methods of inhibiting pathological conditions related to organ systems which respond to estrogen agonists comprising administering to a mammal in need of such treatment an effective amount of a compound of formula I ... | 08/14/2001 |
| 6268509 | Parasiticidal pyrazoles Compounds of formula (I) ##STR1## or pharmaceutically, veterinarily or agriculturally acceptable salts thereof, or pharmaceutically, veterinarily or agriculturally acceptable solvates of either entity, wherein R1 is 2,4,6-trisubsituted phenyl ... | 07/31/2001 |
| 6174903 | Imidazolidin-4-one derivatives useful as anticancer agents The present invention relates to compounds of formula 1 ##STR1## and to pharmaceutically acceptable salts and solvates thereof, wherein Z, R, R3 and R4 are as defined herein. The invention also relates to pharmaceutical compositions ... | 01/16/2001 |
| 6121280 | Azabicyclic rotomase inhibitors This invention relates to novel azabicyclic compounds of the formula ##STR1## wherein R1, Q and Z are defined as in the specification, pharmaceutical compositions containing them, and the use of such compounds for the treatment of neurodeg... | 09/19/2000 |
| 6118016 | Process for preparing phenoxyphenylsulfonyl halides A process for preparing phenoxyphenylsulfonyl halides, which are useful intermediates for the preparation of matrix metalloproteinase inhibitors.... | 09/12/2000 |
| 6114568 | Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors The present invention relates to a process for alkylating hindered sulfonamides useful as intermediates in the preparation of matrix metalloproteinase inhibitors.... | 09/05/2000 |
| 6110958 | Pyrrole compounds having parasiticidal properties Compounds of formula (I) ##STR1## wherein the substituents are as defined herein, are antiparasitic agents.... | 08/29/2000 |
| 6107331 | Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions The present invention provides novel methods of inhibiting pathological conditions related to organ systems which respond to estrogen agonists comprising administering to a mammal in need of such treatment an effective amount of a compound of formula I ... | 08/22/2000 |
| 6103716 | Pyrido(3,2,1-ij)-1,3,4-benzoxadiazine A novel compound having antibacterial activity according to the the formula ##STR1## The compound of the present invention may be prepared from (9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido [3,2,1-ij]-1,3,4-benzadiazine-6-... | 08/15/2000 |
| 6090394 | Parasiticidal pyrazoles Compounds of formula (I): ##STR1## or pharmaceutically, veterinarily or agriculturally acceptable salts thereof, or pharmaceutically, veterinarily or agriculturally acceptable solvates of either entity, wherein R1 is 2,4,6-trisubstituted p... | 07/18/2000 |
| 6083965 | N-aryl-1,2,3-triazole compounds for pharmaceutical and veterinary application Compounds of formula (I): ##STR1## wherein the substituents are as defined herein, are antiparasitic agents.... | 07/04/2000 |
| 6080769 | Imidazolidin-4-one derivatives useful as anticancer agents The present invention relates to compounds of formula 1 ##STR1## and to pharmaceutically acceptable salts and solvates thereof, wherein Z, R, R3 and R4 are as defined herein. The invention also relates to pharmaceutical composit... | 06/27/2000 |
| 6075043 | Parasiticidal pyrazoles Compounds of formula (I) or pharmaceutically, veterinarily or agriculturally acceptable salts thereof, or pharmaceutically, veterinarily or agriculturally acceptable solvates of either entity, wherein R1 is 2,4,6-trisubstituted phenyl or 3,5-di... | 06/13/2000 |
| 6057436 | Canine coronavirus S gene and uses therefor The present invention provides the amino acid and nucleotide sequences of a CCV spike gene, and compositions containing one or more fragments of the spike gene for prophylaxis, diagnostic, and treatment of CCV infections.... | 05/02/2000 |
| 6048880 | Pyridylfuran and pyridylthiophene compounds A compound of the formula: ##STR1## and its pharmaceutically effective salts, wherein R1 and R2 are independently selected from the following: (a) hydrogen, halo, R5 --, C2-6 alkenyl, C2-6 alkynyl, ... | 04/11/2000 |
| 6019986 | Parasiticidal pyrazoles Compounds of formula (I): ##STR1## or pharmaceutically, veterinarily or agriculturally acceptable salts thereof, or pharmaceutically, veterinarily or agriculturally acceptable solvates of either entity, wherein R1 is 2,4,6-trisubstituted p... | 02/01/2000 |